A RANDOMIZED TRIAL OF ADJUVANT THALIDOMIDE VERSUS OBSERVATION IN PATIENTS WITH COMPLETELY RESECTED HIGH RISK RENAL CELL CARCINOMA

OBJECTIVES: Thalidomide has demonstrated modest activity in patients with metastatic renal cell carcinoma (RCC). We evaluated the role of adjuvant thalidomide after complete resection of high-risk RCC. METHODS: Eligibility criteria for enrollment on this randomized trial included any histological su...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Urology
Päätekijät: Margulis, Vitaly, Matin, Surena F., Tannir, Nizar, Tamboli, Pheroze, Shen, Yu, Lozano, Marisa, Swanson, David A., Jonasch, Eric, Wood, Christopher G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2008
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723280/
https://ncbi.nlm.nih.gov/pubmed/18950837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2008.08.476
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia